Physician profile
Prempal Singh
NPI 1396787453
$2,246.57
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $113 · 2021: $181 · 2022: $703 · 2023: $301 · 2024: $213 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $738.10 | 2019-2024 | Xarelto |
| Abbott Laboratories | $290.12 | 2022 | |
| Pfizer INC. | $215.54 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $202.16 | 2019-2023 | |
| Boston Scientific Corporation | $161.91 | 2022-2025 | Watchman Flx |
| Corium, LLC | $118.39 | 2023 | Adlarity |
| E.R. Squibb & Sons, L.L.C. | $108.96 | 2020-2024 | Eliquis |
| Mallinckrodt Hospital Products INC. | $105.54 | 2024-2025 | Terlivaz |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.50 | 2019-2025 | Lifevest |
| Lilly USA, LLC | $91.84 | 2019 | |
| Abbvie INC. | $78.06 | 2021-2025 | |
| Chiesi USA, INC. | $18.49 | 2022 | |
| Inari Medical, INC. | $16.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prempal Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.